Wall Street at a standstill in holiday lull ahead of new US economic data
By ELAINE KURTENBACH and MATT OTT, Associated Press Business Writers
Markets are flat early Tuesday in holiday-thinned trading before head of the release of new data on how the U.S. economy fared in the third quarter.
Related Articles
-
As Orlando woos overseas visitors, Trump’s social media plan for tourists sparks concerns -
Cloudy future for bourbon has Jim Beam closing Kentucky distillery for a year -
Waymos blocked roads and caused chaos during San Francisco power outage -
Instacart ends a program where users could see different prices for the same item at the same store -
What to do with a windfall
Futures for the S&P 500, the Dow Jones Industrial Average and Nasdaq are all essentially unchanged before the opening bell.
Shares of the Danish pharmaceutical company Novo Nordisk jumped more than 7% overnight after U.S. regulators approved a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. Novo’s Wegovy is a GLP-1 drug that works like widely used injectables to mimic a natural hormone that controls appetite and feelings of fullness.
